Big Names at MDACC

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Thomas Buchholz is the chair of the department of radiation oncology and a leader in the field of breast cancer radiation treatment. He publishes a paper pretty much once a month so he would be good IMO.
 
Patricia Eifel is a leader in Gyn onc, Chris Crane is a respected GI onc, Kian Ang is very well respected, as is Eric Chang for head and neck and CNS tumors (respectively). There are numerous others but this should be a good starting point, and more than enough as you probably can't use more than one or two LORs from MD Anderson if it isn't your home institution.
 
Cox, Buchholz, Ang, Eifel, Kuban, and Crane are the biggest names
 
GI Service: I would highly recommend Dr. Prajnan Das on the GI service. Dr. Crane is great, but he's often traveling.

THORACIC: Dr. Cox is mostly at the Proton Center, but always attends conferences and tumor boards. I'm not sure Dr. Komaki works with medical students.

PROSTATE: Dr. Kuban is a sweetheart and a great teacher. So is Dr. Seungtaek Choi.

GYN: Dr. Eifel, definitely.

H&N: Dr. Ang is efficient and good to work with, but he doesn't see many patients (travels a lot; there's a "Where in the World is Dr. Ang Today?" poster in the clinic). He is nice to medical students and junior residents, but usually the senior residents end up on his service. I think it would be good to be on a team with some of the younger faculty members (Beadle, Gunn, Shah), who are excellent teachers and you'd get exposure during Chart Rounds. Rosie is well known, but I think you'd get more out of working with someone else.

LYMPHOMA: Drs. Dabaja and Reed are both great, teach a lot.

CNS: Drs. Chang and/or McAleer are wonderful teachers.
 
MS3 from west coast med school hoping to do an away at MDACC. what are some of the big names there to try to work with and get a letter from?

You can always check for yourself who has EVER gotten NIH grants and who has current grants at projectreporter.nih.gov
 
I would venture a guess that there are perhaps only 25 folks TOTAL (MD or MD/PhD) in rad onc who have current NIH research funding (i.e. R01, R03, R21....)
 
Last edited:
I would venture a guess that there are perhaps only 25 folks TOTAL (MD or MD/PhD) in rad onc who have current NIH research funding (i.e. R01, R03, R21....)

Really? Why do you think that's the case? Obviously academic rad onc is a very small field, but since 1. cancer is very fundable and 2. those in academics appear to be very productive, why the lack of NIH $$$?
 
Simple. Rad Onc reimburses WAY more than Med Onc. Thus if investigators are in clinic for only one or two days a week that's a tremendous loss of revenue for the department. The grants they pull in only cover a small fraction of their potentially billable clinical activity. Also Rad Onc departments tend to be small and most can only afford a handful of lab-based investigators.
 
Exactly as Gfunk states and yes its a relatively small field. There are a number of faculty who are PhDs who have NIH research funding and several departments are rather well represented as one can find from NIH data, but the number or MDs or MD/PhDs who have funding is quite small.
 
Top